{"title":"肺癌的免疫治疗:生物标志物的现状和分析","authors":"艳芳 贾","doi":"10.12677/wjcr.2023.132006","DOIUrl":null,"url":null,"abstract":"Lung cancer is a leading cause of death among cancer patients worldwide. Despite the progressive therapeutic effects of chemotherapy and molecular-targeted therapies, they also have their own limitations. Immunotherapy has recently become the most effective new therapy, and now the enthusiasm for immunotherapy of medical workers around the world has risen significantly. In this review, we will discuss the current role of immunotherapy in lung cancer, the biomarkers of the response to immunotherapy and resistance to immunotherapy.","PeriodicalId":286101,"journal":{"name":"World Journal of Cancer Research","volume":"17 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Immunotherapy in Lung Cancer: Current Landscape and Analysis of Biomarkers\",\"authors\":\"艳芳 贾\",\"doi\":\"10.12677/wjcr.2023.132006\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Lung cancer is a leading cause of death among cancer patients worldwide. Despite the progressive therapeutic effects of chemotherapy and molecular-targeted therapies, they also have their own limitations. Immunotherapy has recently become the most effective new therapy, and now the enthusiasm for immunotherapy of medical workers around the world has risen significantly. In this review, we will discuss the current role of immunotherapy in lung cancer, the biomarkers of the response to immunotherapy and resistance to immunotherapy.\",\"PeriodicalId\":286101,\"journal\":{\"name\":\"World Journal of Cancer Research\",\"volume\":\"17 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"World Journal of Cancer Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12677/wjcr.2023.132006\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Cancer Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12677/wjcr.2023.132006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Immunotherapy in Lung Cancer: Current Landscape and Analysis of Biomarkers
Lung cancer is a leading cause of death among cancer patients worldwide. Despite the progressive therapeutic effects of chemotherapy and molecular-targeted therapies, they also have their own limitations. Immunotherapy has recently become the most effective new therapy, and now the enthusiasm for immunotherapy of medical workers around the world has risen significantly. In this review, we will discuss the current role of immunotherapy in lung cancer, the biomarkers of the response to immunotherapy and resistance to immunotherapy.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
